Angioedema beyond histamine: An educational case series

Acta Clinica Belgica

Volumn 64, Issue 6, 2009, Pages 520-528

  De Knop, K J ^a   Hagendorens, M M ^a   Stevens, W J ^a   De Clerck, L S ^a   Ebo, D G ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Angio edema; Angiotensine converting enzyme inhibitor; Bradykinin; C1 esterase inhibitor; Sartane

Indexed keywords

ANTIHISTAMINIC AGENT; BISOPROLOL; BISOPROLOL EG; BRADYKININ; DAPSONE; HISTAMINE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; LOSARTAN; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BASOPHIL DEGRANULATION; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; FEMALE; HODGKIN DISEASE; HUMAN; HYPERTENSION; MALE; MAST CELL DEGRANULATION; MEDIATOR RELEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 75149162959     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2009.089     Document Type: Article

References (45)

1. Lin RY, Shah SN. Increasing hospitalizations due to angioedema in the United States. Ann Allergy Asthma Immunol 2008; 101:185-92.
2. Temino VM, Peebles RS, Jr. The spectrum and treatment of angioedema. Am J Med 2008; 121:282-6.
3. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallelic angioedema: role of bradykinin. Allergy 2007; 62:842-56.
4. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351:1693-7.
5. Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int lmmunopharmacol 2003;3:311-7.
6. Byrd JB, Adam A, Brown NJ. Angiotensin-Converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 2006; 26:725-37.
7. Malde B, Regalado J, Greenberger PA. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 2007; 98:57-63.
8. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA, Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008; 100:327-32.
9. Campbell DJ, Krum H, Esler MD. Losartan increases bradykinin levels in hypertensive humans. Circulation 2005; 111:315-20.
10. Hellebrand MC, Kojda G, Hoffmann TK, Bas M. (Angioedema due to ACE inhibitors and AT(1) receptor antagonists). Hautarzt 2006;57:808-10.
11. Haymore BR, Yoon J, Mikita CP, Klote MM, DeZee KJ. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol 2008;101:495-9.
12. Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 2004; 17:103-11.
13. Schreiber AD, Kaplan AP, Austen KF. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest 1973; 52:1402-9.
14. Davis AE, III. C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988; 6:595-628.:595-628.
15. Nielsen EW, Johansen HT, Hogasen K, Wuillemin W, Hack CE, Mollnes TE. Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema. Scand J Immunol 1996; 44:185-92.
16. Cugno M, Cicardi M, Bottasso B et al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 1997; 89:3213-8.
17. Davis AE, III. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am 2006;26:633-51.
18. Varga L, Szeplaki G, Laki J et al. Depressed activation of the lectin pathway of complement in hereditary angioedema. Clin Exp Immunol 2008; 153:68-74.
19. Cicardi M, Zingale LC. The deficiency of C1 inhibitor and its treatment. Immunobiology 2007; 212:325-31.
20. Joseph K, Tuscano TB, Kaplan AP. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol 2008; 101:279-86.
21. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000; 356:213-7.
22. Binkley KE, Davis A, III. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000; 106:546-50.
23. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 2006; 343:1286-9.
24. Cichon S, Martin L, Hennies HC et al. Nothen MM. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 2006; 79:1098-104.
25. Farsetti A, Misiti S, Citarella F et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology 1995; 136:5076-83.
26. Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med 1999; 106:650-4.
27. Gupta S, Yu F, Klaustermeyer WB. New-variant hereditary angioedema in three brothers with normal C1 esterase inhibitor level and function. Allergy 2004; 59:557-8.
28. Bork K, Gul D, Dewald G. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men. Br J Dermatol 2006; 154:542-5.
29. Gompels MM, Lock RJ, Abinun M et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139:379-94.
30. Bowen T, Cicardi M, Bork K et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008; 100:S30-S40.
31. Agostoni A, ygoren-Pursun E, Binkley KE et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114:S51-131.
32. Zingale LC, Beltrami L, Zanichelli A et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006; 175:1065-70.
33. Ebo DG, Stevens WJ. Hereditary angioneurotic edema: review of the literature. Acta Clin Belg 2000; 55:22-9.
34. Farkas H, Varga L, Szeplaki G, Visy B, Harmat G, Bowen T. Management of hereditary angioedema in pediatric patients. Pediatrics 2007; 120:e713-e722.
35. Zuraw BL, Christiansen SC. New promise and hope for treating hereditary angioedema. Expert Opin Investig Drugs 2008; 17:697-706.
36. Grattan CE. Autoimmune urticaria. Immunol Allergy Clin North Am 2004; 24:163-81, v.
37. Ozdemir O. Idiopathic (autoimmune) chronic urticaria. Allergy Asthma Proc 2006; 27:431-4.
38. Boguniewicz M. The autoimmune nature of chronic urticaria. Allergy Asthma Proc 2008; 29:433-8.
39. Ebo DG, Sainte-Laudy J, Bridts CH et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy 2006;61:1028-39.
40. Ebo DG, Bridts CH, Hagendorens MM, Aerts NE, De Clerck LS, Stevens WJ. Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin Cytom 2008; 74:201-10.
41. Gyimesi E, Sipka S, Danko K et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria. Br J Dermatol 2004; 151:388-96.
42. De Swerdt A., Van Den KC, Kasran A et al. Detection of basophilactivating IgG autoantibodies in chronic idiopathic Urticaria by induction of CD 63. J Allergy Clin Immunol 2005; 116:662-7.
43. Frezzolini A, Provini A.Teofoli P, Pomponi D, De PO. Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria. Allergy 2006; 61:1071-7.
44. Altrich M, Halsey J, Altman L Comparison of the in vivo autologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria. Allergy Asthma Proc 2008.
45. Weiler CR, van Dellen RG. Genetic test indications and interpretations in patients with hereditary angioedema. Mayo Clin Proc 2006; 81:958-72.